Related Experiment Video
Updated: May 31, 2026
08:26
Luminophore Formation in Various Conformations of Bovine Serum Albumin by Binding of Gold(III)
Published on: August 31, 2018
Gold compounds as therapeutic agents for human diseases
Susan J Berners-Price1, Aleksandra Filipovska
1Institute for Glycomics, Gold Coast Campus, Griffith University, Queensland 4222, Australia. s.berners-price@griffith.edu.au
Metallomics : Integrated Biometal Science
|July 15, 2011
Summary
Gold compounds show renewed promise as versatile drugs for various diseases. Research focuses on targeting cellular components to treat cancers, arthritis, and infections by addressing protein dysfunction.
Area of Science:
- Medicinal Chemistry
- Nanomedicine
- Pharmacology
Background:
- Gold compounds have a long history in medicine, notably Au(I) for rheumatoid arthritis.
- Recent research explores novel gold(I) and gold(III) compounds for diverse therapeutic applications.
- Understanding gold's mechanism of action is key to developing new disease treatments.
Purpose of the Study:
- To discuss the rationale behind designing gold compounds for specific cellular targets.
- To highlight recent advancements and discoveries in gold-based drug development.
- To explore the potential of gold compounds in treating diseases linked to protein dysfunction.
Main Methods:
- Review of existing literature on gold compounds in medicine.
- Analysis of recent research findings on gold-based drug design and application.
- Discussion of novel discoveries and their implications for disease treatment.
Main Results:
- Gold compounds are being developed to target cellular components in cancer, arthritis, and infectious diseases.
- New disease targets have been identified, enhancing understanding of gold compound mechanisms.
- Gold compounds show potential for treating diseases related to selenol and thiol protein dysfunction.
Conclusions:
- Gold compounds offer a versatile platform for developing powerful new drugs.
- Targeted design of gold compounds can alleviate symptoms of various human diseases.
- Further research into gold's interaction with selenol and thiol proteins is warranted.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:20Immunogold Electron Microscopy
Immunoelectron microscopy utilizes immunogold labeling of endogenous proteins with specific antibodies to detect and localize these proteins in cells and tissues. The procedure provides insights into the distribution and quantification of protein under different stimulation conditions offering clues about their functions. Conjugating highly electron-dense gold particles with primary or secondary antibodies allow antigen detection on and within cells, with high resolution and specificity.
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:15G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
01:24Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...